Quanterix (QTRX) Restructuring Costs (2022 - 2023)
Quanterix posted quarterly Restructuring Costs of -$33000.0 for Q1 2023, down 110.03% on a QoQ basis from $329000.0 in Q4 2022.
Quanterix (QTRX) has 2 years of Restructuring Costs data on file, last reported at -$33000.0 in Q1 2023.
- For the quarter ending Q1 2023, Restructuring Costs changed N/A year-over-year to -$33000.0; the trailing twelve-month figure through Jun 2023 stood at $3.7 million (changed N/A YoY), and the FY2022 full-year result was $3.8 million, changed N/A from the prior year.
- Restructuring Costs for Q1 2023 stood at -$33000.0, down from $329000.0 in the prior quarter.
- Across five years, Restructuring Costs topped out at $3.4 million in Q3 2022 and bottomed at -$33000.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -33,000.00 |
| Dec 31, 2022 | 329,000.00 |
| Sep 30, 2022 | 3.43 Mn |